Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
China Pharma Holdings Inc
CPHI | US
0.59
USD-0.06
-8.96%
CPHI | US
About China Pharma Holdings Inc
Sector
Healthcare
Industry
Drug Manufacturers - Major
Earnings date
30/06/2024
As of date
23/04/2026
Close
0.59
Open
0.64
High
0.64
Low
0.59
View Less
CPHI | US
Risk
66.3
Sharpe
-0.86
Luna's Score
39/100
Recommendation
Sell
Luna says (CPHI | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
65.8%1 month
66.3%3 months
94.9%6 months
80.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.66
Debt to equity
0.55
Debt to assets
0.28
Ent. to EBITDA
-225.89
Ent. to rev.
1.37
PEG
-
Other Fundamentals
EBITDA
-1.35M
MarketCap
10.13M
MarketCap(USD)
10.13M
Div. yield
-
Op. margin
-150.44
Erngs. growth
-
Rev. growth
-15.80
Ret. on equity
-74.89
Short ratio
0.22
Short perc.
1.22
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.15
Range1M
0.15
Range3M
0.93
Volumes: Market Activity
Rel. volume
0.73
Price X volume
13.26K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -225.89 | - | Cheaper |
| Ent. to Revenue | 1.37 | - | Cheaper |
| PE Ratio | - | 41.17 | - |
| Price to Book | 0.66 | 11.46 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 94.90 | - | Riskier |
| Debt to Equity | 0.55 | 1.72 | Cheaper |
| Debt to Assets | 0.28 | 0.31 | Par |
| Market Cap | 10.13M | - | Emerging |
